Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs.
about
Allometry of factor VIII and informed scaling of next-generation therapeutic proteins.Animal models of hemophilia and related bleeding disorders.Pharmacokinetics and pharmacodynamics of turoctocog alfa and N8-GP in haemophilia A dogsTuroctocog alfa (NovoEight®)--from design to clinical proof of concept.Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A
P2860
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics and ex vivo w ...... II (N8) in haemophilia A dogs.
@en
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII
@nl
type
label
Pharmacokinetics and ex vivo w ...... II (N8) in haemophilia A dogs.
@en
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII
@nl
prefLabel
Pharmacokinetics and ex vivo w ...... II (N8) in haemophilia A dogs.
@en
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII
@nl
P2093
P2860
P1433
P1476
Pharmacokinetics and ex vivo w ...... II (N8) in haemophilia A dogs.
@en
P2093
E P Merricks
N Defriess
T C Nichols
P2860
P304
P356
10.1111/J.1365-2516.2011.02580.X
P577
2011-06-20T00:00:00Z